| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680471 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018 | 9 Pages |
Abstract
MK-7622 (45Â mg) does not improve cognition or function when used as adjunctive therapy in mild-to-moderate Alzheimer's disease.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tiffini Voss, Jerry Li, Jeffrey Cummings, Martin Farlow, Christopher Assaid, Samar Froman, Heather Leibensperger, Linda Snow-Adami, Kerry Budd McMahon, Michael Egan, David Michelson,